# Multi‐omics technologies and molecular biomarkers in brain tumor‐related epilepsy

*PRI Rank #20 · Topics and Trends in Most Cited Epilepsy research and treatment Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/epilepsy-research-and-treatment/2026/rank-20*

| Field | Value |
| --- | --- |
| Rank | #20 |
| 18m citations | 27 |
| Journal | CNS Neuroscience & Therapeutics |
| Year | 2024 |
| DOI | 10.1111/cns.14717 |
| Corresponding authors | Yaoqiang Du, Wei Zhang, Lisheng Chu |
| Institution | Zhejiang Provincial People's Hospital, China |

**Ranking page:** [Topics and Trends in Most Cited Epilepsy research and treatment Papers, Class of 2026](https://pri.pepkio.com/top-papers/epilepsy-research-and-treatment/2026)

**Paper link:** [10.1111/cns.14717](https://doi.org/10.1111/cns.14717)

## Topics

Brain tumor-related epilepsy (BTRE) · Multi-omics technologies · Genomics · Transcriptomics · Epigenomics · Proteomics · Metabolomics · BRAF V600E variant · IDH variants · D2HG overproduction · FOXO4 · VLGR1 · miR-128 · miRNA-196b · lncRNA UBE2R2-AS1 · Protein acetylation · AQP4 · BCL2A1 · Ki-67 · PI3K/AKT/mTOR pathway

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Epilepsy research and treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/epilepsy-research-and-treatment/2026. Accessed 2026-07-14.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```